MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
Month: March 2023
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and Full Year 2022 Financial Results
Quoin announced dosing of first patient in double blinded clinical study to evaluate QRX003 for…
ProMIS Neurosciences Announces Full Year 2022 Financial Results and Recent Highlights
TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 08, 2023 (GLOBE NEWSWIRE) — Completed all preclinical studies…
SpringWorks Therapeutics Announces New England Journal of Medicine Publication of Phase 3 DeFi Trial Evaluating Nirogacestat in Adults with Desmoid Tumors
– Nirogacestat Treatment Significantly Improved Progression-Free Survival, Objective Response Rate and Key Patient Reported Outcomes…
MDxHealth Announces Update of Outstanding Shares and Voting Rights
NEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET IRVINE, CA, and…
Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Calvin Choi Appointed as a Member of Inaugural Editorial Board of FinanceAsia
NEW YORK & SINGAPORE & HONG KONG–(BUSINESS WIRE)–Dr. Calvin Choi, chairman of AMTD Group and…
Medexus Announces US$58.5 million in New Credit Facilities
TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today…
Cellectis Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Entered into a €40 million credit facility with the European Investment Bank and closed an…
Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH…
Clene to Announce New CNM-Au8® Data From the Healey ALS Platform Trial
Webcast set for 7:30 a.m. ET on March 9 SALT LAKE CITY, March 08, 2023…
Jasper Therapeutics Reports Fiscal 2022 Financial Results and Provides a Business Update
Announced Expansion of Briquilimab (formerly known as JSP191) Development Strategy to Include Chronic Spontaneous Urticaria…
Vaxart to Host Full Year 2022 Business Update and Financial Results Conference Call on March 15
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 08, 2023…
Vir Biotechnology to Participate in the Barclays Global Healthcare Conference
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Supernus to Participate in Two Upcoming Investor Conferences
ROCKVILLE, Md., March 08, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
Viracta Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision…
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates
Company to participate in Type C meeting for IV Tramadol with FDA on March 9,…
Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 08, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ:…
Neurona Therapeutics Announces Presentation at the Oppenheimer 33rd Annual Healthcare Conference
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) — Neurona Therapeutics, a clinical-stage biotherapeutics company advancing…